close

Enter

Log in using OpenID

Gene Therapy Market To Rear Excessive Growth During 2018-2026

embed
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made inco
Gene Therapy Market Foresees Skyrocketing
Growth in the Coming Years 2018-2026
Gene Therapy Market, by Gene Therapy Type (Germline Gene Therapy and
Somatic Gene Therapy), by Type of Vector (Viral Vector and Non-viral Vector),
by Disease Indication (Cardio Vascular Diseases, Cancer, Genetic Disorders,
Neuro Disorders, Infectious Diseases, and Others), and by Geography (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size,
Share, Outlook, and Opportunity Analysis, 2018-2026
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for
producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result
of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy
gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated
gene causes missing of the important protein, with the help of gene therapy normal copy of that missing
or faulty protein can be introduced to restore the function of the protein. All over the world, gene
therapy is being extensively studied by the researchers for the treatment of various diseases such as
HIV, Cancer, Parkinson’s disease, hemophilia and even immune deficiencies through various
approaches. Click To Read More On Gene Therapy Market.
Three primary approaches being practiced in the gene therapy are substituting a mutated gene with the
healthier one, disabling a mutated gene that is functionally inappropriate and introducing a novel gene
in the body to fight a disease. In the gene therapy treatment, vectors are responsible for insertion of
functional gene into the genome of an individual tissues and cells, one of the most common vectors are
viruses. The gene therapy treatment which was once considered as unfeasible, has now become a trend
among small and big companies.
Gene Therapy Market – Regional Insights
North America holds a dominant position in the global gene therapy market, owing to well-established
healthcare facilities, extensive research and development activities, high per capita healthcare
expenditure, and promising medical reimbursement policies in the region. For instance, in 2018, the
U.S government approved US$ 3 billion, for The National Institutes of Health research funds.
Additionally, rising prevalence of cancer and various chronic diseases has boosted the demand for gene
therapy in North America. For instance, According to 2018 American Cancer Society report cancer was
responsible for 609,640 cancer deaths in U.S. alone, so Furthermore, Asia Pacific is projected to
witness significant growth in the global gene therapy manufacturing market in the near future, owing to
its owing to rising number of vulnerable population to various chronic diseases and wide availability of
innovative products offering better solutions to the patients at marginally lower costs. For instance, in
2017, a group of researchers led by the National Cancer Center Japan (NCC), together with Toray
Industries, Inc. developed a new method that could detect thirteen different cancer types with a single
drop of blood.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/1774
Gene Therapy Market – Competitive Advances
Key players operating in the global gene therapy market include GlaxoSmithKline plc, Bluebird Bio,
Inc., Adaptimmune Therapeutics plc, Celgene Corporation, Shanghai Sunway Biotech Co. Ltd., Merck
KGaA, Transgene SA, and OncoGenex Pharmaceuticals, Inc.
Gene Therapy Market – Dynamics
Demand for gene therapy is significantly increasing due to increasing number of patients suffering
from hereditary disorders, cancer, HIV, and various chronic diseases. For instance, 2018 American
Cancer Society report showed cancer was responsible for 609,640 deaths in the U.S. Moreover, in
2017, WHO reported 1.0 million deaths were caused due to HIV-related illnesses worldwide.
Increasing technological developments, innovations, and clinical and pre-clinical trials. According to
published article in 2014 Regenerative Medicine reports 4749 registries of clinical trials related to stem
cell treatment. Several diseases are likely to propel growth of the gene therapy market size during the
forecast period. Moreover, increasing research and development funding by government agencies and
commercial market players for the development of innovative, efficient, and safer gene therapy
practices is boosted the market growth. Furthermore, growing awareness and community acceptance of
gene therapy for various disease treatments is propelling growth of the market.
Market Taxonomy
On the basis of gene therapy type, the global gene therapy market is segmented into:
•Germline Gene Therapy
•Somatic Gene Therapy
On the basis of type of vector, the global gene therapy market is segmented into:
•Viral Vector
•Non-viral Vector
On the basis of disease indication, the global gene therapy market is segmented into:
•Cardio Vascular Diseases
•Cancer
•Genetic Disorders
•Neuro Disorders
•Infectious Diseases
•Others
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran303   documents Email
Document
Category
Health and Medicine
Views
8
File Size
386 KB
Tags
gene
1/--pages
Report inappropriate content